Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression

Detalhes bibliográficos
Autor(a) principal: Alexandrino, Kedma Anne Lima Gomes
Data de Publicação: 2024
Outros Autores: Aquino, Alana Mara Inácio de, Marques, Clebya Candeia de Oliveira, Oliveira, Milena Edite Casé de, Faria, Jairo Rocha de, Andrade, Suellen Mary Marinho dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Bioscience journal (Online)
Texto Completo: https://seer.ufu.br/index.php/biosciencejournal/article/view/67875
Resumo: Numerous patients with mild cognitive impairment (MCI) or Alzheimer’s disease (AD) are refractory to pharmacological treatment, and non-invasive brain neurostimulation has been investigated as another possibility for improving cognition. The performed meta-analysis and meta-regression verified predictors of efficacy, tolerability, and discontinuation of transcranial direct current stimulation (tDCS) for treating MCI or AD. The analyzed studies used the Mini-Mental State Exam, Montreal Cognitive Assessment, or Alzheimer's Disease Assessment Scale - Cognitive Subscale scores as outcome measures. Databases (PubMed, Embase, and Web of Science - primary collection) were searched, resulting in 12 published randomized and controlled trials. The risk of bias assessment was based on Cochrane Review recommendations, considering study characteristics. Other evaluated outcomes were the number of adverse effects (tolerability) and dropouts. Overall and anodal tDCS improved cognition compared to the sham protocol. Group comparisons did not show statistically significant differences for adverse effects and dropouts. Session duration was a response predictor, as stimulations of up to 20 minutes for ten days or more improved the outcome achievement. The AD diagnosis covariate also affected efficacy. The findings should be interpreted carefully in clinical practice because the stimulation effect may vary among subjects.
id UFU-14_2899433b689bc871ac94b2e30a484a4e
oai_identifier_str oai:ojs.www.seer.ufu.br:article/67875
network_acronym_str UFU-14
network_name_str Bioscience journal (Online)
repository_id_str
spelling Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regressionAlzheimer’s diseaseMild cognitive impairmentTranscranial direct current stimulation. Health SciencesNumerous patients with mild cognitive impairment (MCI) or Alzheimer’s disease (AD) are refractory to pharmacological treatment, and non-invasive brain neurostimulation has been investigated as another possibility for improving cognition. The performed meta-analysis and meta-regression verified predictors of efficacy, tolerability, and discontinuation of transcranial direct current stimulation (tDCS) for treating MCI or AD. The analyzed studies used the Mini-Mental State Exam, Montreal Cognitive Assessment, or Alzheimer's Disease Assessment Scale - Cognitive Subscale scores as outcome measures. Databases (PubMed, Embase, and Web of Science - primary collection) were searched, resulting in 12 published randomized and controlled trials. The risk of bias assessment was based on Cochrane Review recommendations, considering study characteristics. Other evaluated outcomes were the number of adverse effects (tolerability) and dropouts. Overall and anodal tDCS improved cognition compared to the sham protocol. Group comparisons did not show statistically significant differences for adverse effects and dropouts. Session duration was a response predictor, as stimulations of up to 20 minutes for ten days or more improved the outcome achievement. The AD diagnosis covariate also affected efficacy. The findings should be interpreted carefully in clinical practice because the stimulation effect may vary among subjects.Universidade Federal de Uberlândia2024-01-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://seer.ufu.br/index.php/biosciencejournal/article/view/6787510.14393/BJ-v40n0a2024-67875Bioscience Journal ; Vol. 40 (2024): Continuous Publication; e40006Bioscience Journal ; v. 40 (2024): Continuous Publication; e400061981-3163reponame:Bioscience journal (Online)instname:Universidade Federal de Uberlândia (UFU)instacron:UFUenghttps://seer.ufu.br/index.php/biosciencejournal/article/view/67875/37832Brasil; Contemporary Copyright (c) 2024 Kedma Anne Lima Gomes Alexandrino, Alana Mara Inácio de Aquino, Clebya Candeia de Oliveira Marques, Milena Edite Casé de Oliveira, Jairo Rocha de Faria, Suellen Mary Marinho dos Santos Andradehttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAlexandrino, Kedma Anne Lima GomesAquino, Alana Mara Inácio deMarques, Clebya Candeia de Oliveira Oliveira, Milena Edite Casé deFaria, Jairo Rocha deAndrade, Suellen Mary Marinho dos Santos2024-04-03T12:44:10Zoai:ojs.www.seer.ufu.br:article/67875Revistahttps://seer.ufu.br/index.php/biosciencejournalPUBhttps://seer.ufu.br/index.php/biosciencejournal/oaibiosciencej@ufu.br||1981-31631516-3725opendoar:2024-04-03T12:44:10Bioscience journal (Online) - Universidade Federal de Uberlândia (UFU)false
dc.title.none.fl_str_mv Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
title Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
spellingShingle Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
Alexandrino, Kedma Anne Lima Gomes
Alzheimer’s disease
Mild cognitive impairment
Transcranial direct current stimulation.
Health Sciences
title_short Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
title_full Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
title_fullStr Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
title_full_unstemmed Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
title_sort Predictors of efficacy, tolerability and discontinuation of Transcranial Direct Current Stimulation (tDCS) for Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD): a meta-analysis and meta-regression
author Alexandrino, Kedma Anne Lima Gomes
author_facet Alexandrino, Kedma Anne Lima Gomes
Aquino, Alana Mara Inácio de
Marques, Clebya Candeia de Oliveira
Oliveira, Milena Edite Casé de
Faria, Jairo Rocha de
Andrade, Suellen Mary Marinho dos Santos
author_role author
author2 Aquino, Alana Mara Inácio de
Marques, Clebya Candeia de Oliveira
Oliveira, Milena Edite Casé de
Faria, Jairo Rocha de
Andrade, Suellen Mary Marinho dos Santos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Alexandrino, Kedma Anne Lima Gomes
Aquino, Alana Mara Inácio de
Marques, Clebya Candeia de Oliveira
Oliveira, Milena Edite Casé de
Faria, Jairo Rocha de
Andrade, Suellen Mary Marinho dos Santos
dc.subject.por.fl_str_mv Alzheimer’s disease
Mild cognitive impairment
Transcranial direct current stimulation.
Health Sciences
topic Alzheimer’s disease
Mild cognitive impairment
Transcranial direct current stimulation.
Health Sciences
description Numerous patients with mild cognitive impairment (MCI) or Alzheimer’s disease (AD) are refractory to pharmacological treatment, and non-invasive brain neurostimulation has been investigated as another possibility for improving cognition. The performed meta-analysis and meta-regression verified predictors of efficacy, tolerability, and discontinuation of transcranial direct current stimulation (tDCS) for treating MCI or AD. The analyzed studies used the Mini-Mental State Exam, Montreal Cognitive Assessment, or Alzheimer's Disease Assessment Scale - Cognitive Subscale scores as outcome measures. Databases (PubMed, Embase, and Web of Science - primary collection) were searched, resulting in 12 published randomized and controlled trials. The risk of bias assessment was based on Cochrane Review recommendations, considering study characteristics. Other evaluated outcomes were the number of adverse effects (tolerability) and dropouts. Overall and anodal tDCS improved cognition compared to the sham protocol. Group comparisons did not show statistically significant differences for adverse effects and dropouts. Session duration was a response predictor, as stimulations of up to 20 minutes for ten days or more improved the outcome achievement. The AD diagnosis covariate also affected efficacy. The findings should be interpreted carefully in clinical practice because the stimulation effect may vary among subjects.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufu.br/index.php/biosciencejournal/article/view/67875
10.14393/BJ-v40n0a2024-67875
url https://seer.ufu.br/index.php/biosciencejournal/article/view/67875
identifier_str_mv 10.14393/BJ-v40n0a2024-67875
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufu.br/index.php/biosciencejournal/article/view/67875/37832
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.coverage.none.fl_str_mv Brasil; Contemporary
dc.publisher.none.fl_str_mv Universidade Federal de Uberlândia
publisher.none.fl_str_mv Universidade Federal de Uberlândia
dc.source.none.fl_str_mv Bioscience Journal ; Vol. 40 (2024): Continuous Publication; e40006
Bioscience Journal ; v. 40 (2024): Continuous Publication; e40006
1981-3163
reponame:Bioscience journal (Online)
instname:Universidade Federal de Uberlândia (UFU)
instacron:UFU
instname_str Universidade Federal de Uberlândia (UFU)
instacron_str UFU
institution UFU
reponame_str Bioscience journal (Online)
collection Bioscience journal (Online)
repository.name.fl_str_mv Bioscience journal (Online) - Universidade Federal de Uberlândia (UFU)
repository.mail.fl_str_mv biosciencej@ufu.br||
_version_ 1797069065810870272